Immix Biopharma (IMMX) Cash flow

Compare

193 Followers

Immix Biopharma Cash Flow

IMMX's free cash flow for Q4 2025 was $-11.19M. For the 2025 fiscal year, IMMX's free cash flow was decreased by $-8.89M and operating cash flow was $-11.03M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -23.93M	$ -14.60M	$ -11.37M	$ -7.41M	$ -1.59M
Investing Cash Flow	$ -7.21M	$ -1.18M	$ -52.09K	$ 0.00	$ -802.00
Financing Cash Flow	$ 107.39M	$ 15.95M	$ 15.46M	$ 3.23M	$ 18.85M
End Cash Position	$ 93.93M	$ 17.68M	$ 17.51M	$ 13.44M	$ 17.64M
Free Cash Flow	$ -24.66M	$ -15.77M	$ -11.42M	$ -7.41M	$ -1.59M

Currency in USD